LUVOX

This brand name is authorized in Australia, Brazil, Canada, Ecuador, Japan, Mexico, New Zealand, South Africa

Active ingredients

The drug LUVOX contains one active pharmaceutical ingredient (API):

1 Fluvoxamine UNII 5LGN83G74V - FLUVOXAMINE MALEATE

The mechanism of action of fluvoxamine is thought to be related to selective serotonin re-uptake inhibition in brain neurones. There is minimum interference with noradrenergic processes. Receptor binding studies have demonstrated that fluvoxamine has negligible binding capacity to alpha adrenergic, beta adrenergic, histaminergic, muscarine cholinergic, dopaminergic or serotonergic receptors. Read about Fluvoxamine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LUVOX Tablet	Marketing Authorisation Holder	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AB08	Fluvoxamine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8174F, 8512B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500214010031214, 500214010031314, 500214010031414, 500216120035403
Country: CA	Health Products and Food Branch	Identifier(s): 01919342, 01919369
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29088-11-09
Country: JP	医薬品医療機器総合機構	Identifier(s): 1179039F1036, 1179039F2032, 1179039F3039
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 297M95
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7688, 7689
Country: ZA	Health Products Regulatory Authority	Identifier(s): X/1.2/59, X/1.2/60